Skip to main content
SpringerLink
Log in

Assessing the frequency and types of errors involved in the use of a modified intravenous N-acetylcysteine protocol for acetaminophen overdose

  • Brief Original Research
  • Published:
Canadian Journal of Emergency Medicine Aims and scope Submit manuscript

Abstract

Background

Acetaminophen overdose is a leading cause of acute liver failure in developing countries. N-acetylcysteine (NAC) is a highly effective antidote for acetaminophen hepatotoxicity, typically initiated in the emergency department. Due to a known high rate of errors with the standard three-bag IV NAC protocol, in 2019, the Ontario Poison Center changed to a modified 3% IV NAC one-bag protocol. This study was undertaken to determine the frequency and types of errors associated with the use of this protocol.

Methods

Data were gathered via chart review of Ontario Poison Centre electronic medical record cases identified as receiving IV NAC for acetaminophen overdose between August 1 and September 30, 2022. 218 total charts were identified, and 188 were deemed eligible based on inclusion and exclusion criteria.

Results

Errors were identified in 25% of charts, consisting of dosing errors in 11.7%, stopping errors in 9.0%, initiation errors in 3.7%, and interruptions in therapy in 3.2%. Dosing errors were the most common type of error (44.4%), with overdoses occurring three times more than underdoses. Errors were identified at 39% of geographic locations in the charts reviewed, with similar frequency in Ontario, Manitoba, and Nunavut. Clinical outcomes were similar in charts with and without errors.

Interpretation

The rate of errors identified with this 3% IV NAC one-bag protocol is lower than reported for the standard three-bag protocol, but remains high due to dosing errors. Previously reported issues with prolonged interruptions in therapy with the standard three-bag protocol were low with the current 3% one-bag protocol. Although severe outcomes are rare, IV NAC overdose can be fatal. Identifying local factors in emergency departments that can contribute to administration errors (i.e., dose calculation, pump programming issues) can enhance the safety of this important antidote.

Résumé

Contexte

La surdose d’acétaminophène est l’une des principales causes d’insuffisance hépatique aiguë dans les pays en développement. La N-acétylcystéine (NAC) est un antidote très efficace contre l’hépatotoxicité de l’acétaminophène, généralement initiée au service des urgences. En raison d’un taux élevé connu d’erreurs avec le protocole NAC standard à 3 sacs IV, en 2019, le Centre antipoison de l’Ontario a adopté un protocole NAC à 1 sac IV modifié à 3 %. Cette étude a été entreprise pour déterminer la fréquence et les types d’erreurs associées à l’utilisation de ce protocole.

Méthodes

Les données ont été recueillies au moyen d’un examen des dossiers médicaux électroniques du Centre antipoison de l’Ontario qui ont reçu une dose IV de NAC pour une surdose d’acétaminophène entre le 1 août et le 30 septembre 2022. 218 cartes au total ont été identifiées, et 188 ont été jugées admissibles en fonction de critères d’inclusion et d’exclusion.

Résultats

Des erreurs ont été relevées dans 25 % des dossiers, soit des erreurs de dosage dans 11,7 %, des erreurs d’arrêt dans 9,0 %, des erreurs d’initiation dans 3,7 % et des interruptions du traitement dans 3,2 %. Les erreurs de dosage étaient le type d’erreur le plus courant (44,4 %), les surdoses étant trois fois plus fréquentes que les sous-doses. Des erreurs ont été relevées à 39 % des emplacements géographiques dans les cartes examinées, avec une fréquence similaire en Ontario, au Manitoba et au Nunavut. Les résultats cliniques étaient similaires dans les tableaux avec et sans erreurs.

Interprétation

Le taux d’erreurs identifiées avec ce protocole à un sac NAC IV à 3 % est inférieur à celui du protocole standard à 3 sacs, mais reste élevé en raison d’erreurs de dosage. Les problèmes précédemment rapportés avec les interruptions prolongées du traitement avec le protocole standard à 3 sacs étaient faibles avec le protocole actuel à 3% à un sac. Bien que les résultats graves soient rares, une surdose de NAC IV peut être fatale. L’identification de facteurs locaux dans les services d’urgence qui peuvent contribuer aux erreurs d’administration (c.-à-d. le calcul de la dose, les problèmes de programmation de la pompe) peut améliorer l’innocuité de cet antidote important.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sivilotti MLA, Yarema MC, Juurlink DN. Treating acetaminophen overdose. Can Med Assoc J. 2022;194(15):E554–E554.

    Article  Google Scholar 

  2. Gow PJ, Jones RM, Dobson JL, Angus PW. Etiology and outcome of fulminant hepatic failure managed at an Australian liver transplant unit. J Gastroenterol Hepatol. 2004;19(2):154–9.

    Article  PubMed  Google Scholar 

  3. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N Engl J Med. 1988;319(24):1557–62.

    Article  CAS  PubMed  Google Scholar 

  4. Hayes BD, Klein-Schwartz W, Doyon S. Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose. Ann Pharmacother. 2008;42(6):766–70.

    Article  CAS  PubMed  Google Scholar 

  5. Pettie JM, Caparrotta TM, Hunter RW, Morrison EE, Wood DM, Dargan PI, et al. Safety and efficacy of the SNAP 12-hour acetylcysteine regimen for the treatment of paracetamol overdose. EClinicalMedicine. 2019;11:11–7.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wong A, McNulty R, Taylor D, Sivilotti M, Greene S, Gunja N, et al. The NACSTOP trial: a multicenter, cluster-controlled trial of early cessation of acetylcysteine in acetaminophen overdose. Hepatology. 2019;69(2):774–84.

    Article  CAS  PubMed  Google Scholar 

  7. Mullins ME, Yarema MC, Sivilotti MLA, Thompson M, Beuhler MC, Algren DA, et al. Comment on “Transition to two-bag intravenous acetylcysteine for acetaminophen overdose.” Clin Toxicol. 2020;58(5):433–5.

    Article  Google Scholar 

  8. Institute for Safe Medical Practices Canada. ISMP Canada safety bulletin. 2023. When the antidote causes harm: preventing errors with intravenous acetylcysteine. https://ismpcanada.ca/wp-content/uploads/ISMPCSB2023-i7-Acetylcysteine.pdf. Accessed 22 Dec 2023.

  9. Administration of Scheduled Medications posted on ISMP website. ISMP Medication Safety Alert!2011;16(10):1,3. Available at: www.ismp.org/Newsletters/acutecare/articles/20110519.asp [Internet]. ISMP medication safety alert. Accessed 22 Dec 2023.

  10. Johnson MT, McCammon CA, Mullins ME, Halcomb SE. Evaluation of a simplified N-acetylcysteine dosing regimen for the treatment of acetaminophen toxicity. Ann Pharmacother. 2011;45(6):713–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Western University, London, ON, Canada

    J. Ali

  2. Ontario Poison Centre, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, ON, Canada

    M. Thompson & Connie Mackenzie

  3. Division of Emergency Medicine, St. Michael’s Hospital, Toronto, ON, Canada

    M. Thompson

  4. Divisions of Clinical Pharmacology and Toxicology/Respirology, Western University, London, ON, Canada

    Connie Mackenzie

Authors
  1. J. Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Connie Mackenzie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Connie Mackenzie.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 100 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ali, J., Thompson, M. & Mackenzie, C. Assessing the frequency and types of errors involved in the use of a modified intravenous N-acetylcysteine protocol for acetaminophen overdose. Can J Emerg Med 26, 174–178 (2024). https://doi.org/10.1007/s43678-023-00641-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43678-023-00641-9

Keywords

Search

Navigation